Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPGI
4451
GPGI Inc
GPGI
$4.34B
| $122K | ﹤0.01% |
27,295
+23,618
| +642% | +$110K |
|
4452
Zegna
ZGN
$3.97B
| $122K | ﹤0.01% |
10,548
-3,856
| -27% | -$45.9K |
|
4453
CALL
Becton Dickinson
BDX
$48.8B
| $122K | ﹤0.01% |
+500
| New | +$123K |
|
4454
Valens Semiconductor
VLN
$182M
| $122K | ﹤0.01% |
49,675
| – | – |
|
4455
Pagaya Technologies
PGY
$1.79B
| $122K | ﹤0.01% |
+7,349
| New | +$120K |
|
4456
374Water
SCWO
$39M
| $122K | ﹤0.01% |
8,565
+7,394
| +631% | +$98.7K |
|
4457
Lifecore Biomedical
LFCR
$183M
| $121K | ﹤0.01% |
19,508
-11,403
| -37% | -$79.2K |
|
4458
Acrivon Therapeutics
ACRV
$72.3M
| $120K | ﹤0.01% |
24,484
+10,384
| +74% | +$54.8K |
|
4459
Maplebear
CART
$10.6B
| $119K | ﹤0.01% |
+5,090
| New | +$128K |
|
4460
PUT
Marathon Petroleum
MPC
$84B
| $119K | ﹤0.01% |
800
| – | – |
|
4461
VistaGen Therapeutics
VTGN
$12.6M
| $119K | ﹤0.01% |
+23,077
| New | +$87.3K |
|
4462
KORU Medical Systems
KRMD
$164M
| $118K | ﹤0.01% |
+48,091
| New | +$115K |
|
|
SMC
4463
Summit Midstream
SMC
$424M
| $118K | ﹤0.01% |
6,579
-704
| -10% | -$13.2K |
|
4464
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.4B
| $118K | ﹤0.01% |
870
| – | – |
|
|
MAGN
4465
Magnera Corp
MAGN
$446M
| $118K | ﹤0.01% |
4,670
+2,104
| +82% | +$44.3K |
|
4466
Babcock & Wilcox
BW
$1.4B
| $117K | ﹤0.01% |
80,437
+58,566
| +268% | +$125K |
|
4467
Vor Biopharma
VOR
$1.28B
| $117K | ﹤0.01% |
2,604
+2,243
| +621% | +$92.6K |
|
4468
Citizens
CIA
$231M
| $117K | ﹤0.01% |
43,526
-2,890
| -6% | -$8.94K |
|
4469
iShares US Healthcare Providers ETF
IHF
$1.25B
| $117K | ﹤0.01% |
2,225
| – | – |
|
|
IFN
4470
Aberdeen India Fund
IFN
$502M
| $116K | ﹤0.01% |
6,482
+158
| +2% | +$2.71K |
|
4471
Offerpad Solutions
OPAD
$21.9M
| $116K | ﹤0.01% |
1,129
+202
| +22% | +$18.3K |
|
4472
Richmond Mutual Bancorp
RMBI
$255M
| $115K | ﹤0.01% |
10,030
-948
| -9% | -$10.2K |
|
4473
HireQuest
HQI
$178M
| $115K | ﹤0.01% |
7,479
+6,436
| +617% | +$98.5K |
|
4474
CPI Card Group
PMTS
$282M
| $114K | ﹤0.01% |
5,958
+5,187
| +673% | +$87.9K |
|
4475
System1
SST
$17.4M
| $113K | ﹤0.01% |
5,093
+3,911
| +331% | +$57.9K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.